Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Keith Sweeney Image

      Keith Sweeney, M.D.

      Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

      About Dr. Keith Sweeney

      I am a board certified Anatomic and Clinical Pathology, currently working as assistant professor of breast and molecular pathology in the Division of Pathology and Laboratory Medicine (DPLM) at The University of Texas MD Anderson Cancer Center (UTMDACC). My primary role is to provide breast cancer specimen interpretation and diagnostic services, with a secondary role interpreting molecular genetic data from solid tumor specimens. Administratively, I represent the DPLM in the Faculty Senate and serve as Medical Director of Surgical Pathology at the UTMDACC Northwest Surgical Center. I am currently collaborating with oncologists, surgeons, radiologists, and radiation oncologists on multiple breast cancer-related clinical trials and research projects at MD Anderson Cancer Center. I am motivated to put my training as a fellow in surgical, breast, and molecular genetic pathology to the task of furthering my research interests in studies involving molecular pathways and novel genetic alterations in breast cancer with the potential for targetable therapy. My knowledge and expertise will make me an effective collaborator on the proposed research project.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2015Albany Medical College, Albany, New York, US, MD
      2010The University of Arizona, Tucson, Arizona, US, Molecular and Cellular Biology, BS
      2010The University of Arizona, Tucson, Arizona, US, Physiology, BS in Health Sciences

      Postgraduate Training

      2021-2022Clinical Fellowship, Molecular Genetic Pathology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2020-2021Clinical Fellowship, Selective Breast Pathology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2019-2020Clinical Fellowship, Selective Surgical Pathology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2015-2019Clinical Residency, Anatomic & Clinical Pathology Residency, Stony Brook University Hospital, Stony Brook, New York

      Licenses & Certifications

      2023Molecular Genetic Pathology, American Board of Pathology
      2022Texas Medical License
      2020Anatomic & Clinical Pathology, American Board of Pathology

      Experience & Service

      Administrative Appointments/Responsibilities

      Medical Director of Surgical Pathology at Northwest Surgical and Specialty Care Center, Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present

      Faculty Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - 2025

      Co-Lead Molecular Genetic Pathology Fellow, Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2022

      Program Evaluation Committee for the ACGME Annual Program Evaluation, Stony Brook University Hospital, Stony Brook, NY, 2018 - 2019

      Chief Resident, Pathology, Stony Brook University Hospital, Stony Brook, NY, 2017 - 2018

      Failure Mode and Effects Analysis Committee on "Irreplaceable Specimens Lost", Pathology, Stony Brook University Hospital, Stony Brook, NY, 2017 - 2018

      Intramural Institutional Committee Activities

      Member, Breast Imaging Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, AP Digital Pathology Team, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, AP Leadership Team, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Member, HAL DPLM Executive Ops Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Member, Frozen Section Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Member, NWSSC OR Advisory Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Member, Faculty Wellness/Burnout Working Group, The University of Texas MD Anderson Cancer Center, 2023 - Present

      Honors & Awards

      2025 - PresentOncoPitch 2025 $10,000 Awardee, The University of Texas MD Anderson Cancer Center
      2025 - PresentShirley Stein Scientific Endowment Research Award, The University of Texas MD Anderson Cancer Center
      2023Cum Laude Award - Education Exhibit at the 109th Scientific Assembly and Annual Meeting of the RSNA, Radiological Society of North America (RSNA)
      2023Outstanding Multidisciplinary Faculty Teaching Award, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center
      2022DPLM 2nd Annual Research Symposium, 1st Place Clinical Oral Presentation Award, The University of Texas M.D. Anderson Cancer Center
      2022USCAP ISBP-BCRF Larry Norton MD Award, Trainee Abstract in Breast Pathology, 1st Place in the Research Category, The University of Texas M.D. Anderson Cancer Center
      2021Department of Pathology and Laboratory Medicine Research Grant for Clinical Fellow, The University of Texas M.D. Anderson Cancer Center
      2020Best Subspecialty Fellow Lecture, Department of Pathology, The University of Texas M.D. Anderson Cancer
      2019Outstanding Resident, Department of Pathology, Stony Brook University
      2013MD Trustee Scholarship, Albany Medical College
      2011Top Honors, Summer Research Fellowships Basic Science Category, Poster Presentation Award, 8th Annual Medical Student Investigation Day, Albany Medical College
      2009John P. Foley Award for Academic Excellence, Scholarship, Rogers Corporation, Chandler, AZ
      2008Mortar Board National Honor Society Scholarship, The University of Arizona
      2007Richard C. Berry Science or Engineering Scholar, Scholarship, Rogers Corporation, Chandler, AZ
      2006National Merit Scholar
      2006Valedictorian, Red Mountain High School, Mesa, AZ

      Professional Memberships

      International Society of Breast Pathology

      2022 - Present

      Association for Molecular Pathology

      2021 - Present

      Houston Society of Clinical Pathologists

      2019 - Present

      American Society for Clinical Pathology

      2016 - Present

      College of American Pathologists

      2015 - Present

      United States & Canadian Academy of Pathologists

      2015 - Present

      Suffolk County Society of Pathologists

      2015 - 2019

      American Medical Association

      2010 - 2018

      Selected Presentations & Talks

      Local Presentations

      1. 2025. Breast Pathology: From Intraoperative Assessment to Permanent Evaluation and Reporting Considerations. Invited. Breast Surgical Oncology Education Conference. Houston, Texas, US.
      2. 2025. The Role of Molecular Diagnostics in Breast Cancer Management. Invited. Tutorials on Clinical Genomics Applications. Houston, Texas, US.
      3. 2024. Multidisciplinary Approaches to SLN and ALND Omission Based on the SOUND, SENOMAC, and AMAROS Trials: Pathology Perspective. Panelist. Breast Cancer Clinical and Translational Research (BCCTR) Conference, US.
      4. 2023. Breast Pathology: From Intraoperative Assessment to Permanent Evaluation and Reporting Considerations. Invited. Breast Surgical Oncology Education Conference. Houston, Texas, US.
      5. 2023. Managing Breast Cancer with the Aid of Molecular Testing. Invited. Tutorials on Clinical Genomics Applications. Houston, Texas, US.
      6. 2023. Diagnosing Breast Cancer with Breast Biomarkers and Molecular Testing. Invited. Section of Breast Pathology Lecture. Houston, Texas, US.
      7. 2022. PTEN Alterations in Advanced ER+ Breast Cancer: Correlation with Clinicopathologic and Molecular Features. Conference. MDACC DPLM 2nd Annual Research Symposium. Houston, Texas, US.
      8. 2022. Molecular Profiling of Malignant Spindle Cell Lesions of the Breast: Genetic Alterations of Spindle Cell Metaplastic Carcinoma and Malignant Phyllodes Tumor. Conference. MDACC DPLM 2nd Annual Research Symposium. Houston, Texas, US.
      9. 2011. Expression and Development of EAE in Mice. Poster. Albany Medical College's Eighth Annual Medical Student Investigation Day. Albany, New York, US.
      10. 2010. Mapping the mop3 Gene Relative to the rmr6 Gene. Conference. The University of Arizona Honors College Thesis. Tucson, Arizona, US.

      National Presentations

      1. 2023. The Many Faces of Invasive Lobular Carcinoma. Conference. 109th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA). Chicago, Illinois, US.
      2. 2023. More Than Just Gynecomastia: The Spectrum of Male Breast Pathologies. Poster. Society of Breast Imaging Symposium 2023. National Harbor, Maryland, US.
      3. 2017. Minimum Lung Tumor Cell Threshold in Fine Needle Aspiration Cell Blocks Required for Therapeutic Marker Studies. Poster. ASC’s 65th Annual Scientific Meeting. Phoenix, Arizona, US.
      4. 2017. Paraneoplastic Dermatomyositis with Edema: A Rare Syndrome in a Case of Small Cell Lung Cancer. Poster. 12th Annual MSSNY Resident/Fellow and Medical Student Poster Symposium. Westchester, New York, US.
      5. 2016. Epidemiology of Neurocysticercosis at Stony Brook University Hospital, Long Island, NY. Poster. Infectious Diseases Society of America Annual IDWeek. New Orleans, Louisiana, US.
      6. 2014. Anaphylaxis in an Upstate New York Emergency Department: Triggers and Treatments. Poster. American Academy of Allergy Asthma and Immunology Annual Meeting. San Diego, California, US.
      7. 2011. Establishment of a Mentorship Program Connecting Health Professional Students with Refugee Families. Poster. Family Medicine Education Consortium Northeast Region Meeting. Danvers, Massachusetts, US.

      International Presentations

      1. 2026. Three Topics: HER2-Low and HER2-Ultralow Breast Cancer; Papillary Breast Lesions; Pathological Evaluation of Post-Neoadjuvant Therapy Breast Specimens. Invited. XXVI Peruvian National Congress of Pathology. Cusco, PE.
      2. 2025. Breast Cancer Pathology – Margins, Intraoperative Evaluation, and Assessment After Neoadjuvant Systemic Therapy. Invited. Project NOTRE (Indonesia Breast Cancer ECHO), US.
      3. 2025. Recurring Genes in Fusions in Advanced Breast Carcinoma Detected by Next-Generation Sequencing: Novel BCR and TMPRSS2 Gene Fusions. Poster. USCAP 114th Annual Meeting. Boston, US.
      4. 2024. Multidisciplinary Cancer Center Management of Papillary Lesions of the Breast. Invited. Project NOTRE (Indonesia Breast Cancer ECHO), US.
      5. 2023. Breast Pathology Slide Seminar. Invited. Diagnostic Pathology Updates Conference 2023. Houston, US.
      6. 2022. PTEN Alterations in Advanced ER+ Breast Cancer: Correlation with Clinicopathologic and Molecular Features. Poster. USCAP 111th Annual Meeting. Los Angeles, US.
      7. 2021. ER-/PR+ Breast Cancer Cases Across Two FDA-Approved Platforms: Incidence and Clinicopathologic Correlates. Poster. USCAP 110th Annual Meeting. Palm Springs, US.
      8. 2019. Relationship Between Tumor Grade and Intra-Tumor Genetic Heterogeneity Using the Mutant-Allele Tumor Heterogeneity (MATH) Score with Breast Invasive Ductal Carcinoma Data from The Cancer Genome Atlas (TCGA). Poster. USCAP 108th Annual Meeting. National Harbor, US.
      9. 2018. Next-Generation Sequencing in a Mixed Neuroendocrine-Nonneuroendocrine Neoplasm. Poster. USCAP 107th Annual Meeting. Vancouver, CA.
      10. 2017. An Unexpected Diagnosis of DIPNECH. Poster. CHEST Journal 2017 Annual Meeting. Toronto, CA.
      Read More
      Less

      Grant & Contract Support

      Date: 2025 - Present
      Title:Decoding the co-evolution of cancer subclones and their ecosystem in TNBC multi-organ metastasis
      Funding Source:NIH
      Role:Consult
      ID:PA-20-185
      Date: 2024 - Present
      Title:AccessPath: A Low-Cost, Rugged, End-to-End System for Slide-Free Pathology Based on Computational Microscopy and Pan-Cancer Targeted Vital Dyes
      Funding Source:ARPA-H/NIH
      Role:Co-I
      ID:75N99223R0004
      Date: 2023 - Present
      Title:Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
      Funding Source:NIH/NCI
      Role:Co-I
      ID:1 UH3 CA276603-01A1

      Selected Publications

      Peer-Reviewed Articles

      1. Han, J, Ding, Y, Gan, Q, Sweeney, K, Huang, X, Hameed, N, Weissferdt, A, Wang, Y, Peng, Y, Sun, H. TRPS1 and GATA3 expression in BRG1/SMARCA4-deficient malignant neoplasms. Human Pathology 177:106209, 2026. e-Pub 2026. PMID: 42398545.
      2. Dai, M, San Lucas, FA, Alvarez, HA, Ballester, L, Chen, H, Patel, KP, Rashid, A, Rao, S, Routbort, MJ, Sura, GH, Sweeney, K, Toruner, GA, Wei, P, Yang, RK, Dang, HD, Luthra, R, Roy Chowdhuri, S. Unraveling the nexus. Cancer Cytopathol 134(4):e70090, 2026. e-Pub 2026. PMID: 41891376.
      3. Ye, Q, Law, T, Klippel, D, Albarracin, C, Chen, H, Contreras, A, Ding, Q, Huo, L, Khazai, L, Middleton, LP, Resetkova, E, Sahin, AA, Sun, H, Sweeney, K, Symmans, WF, Wu, Y, Yoon, EC, Krishnamurthy, S. Prospective and Retrospective Analysis of Whole-Slide Images of Sentinel and Targeted Lymph Node Frozen Sections in Breast Cancer. Mod Pathol 38(4), 2025. e-Pub 2025. PMID: 39788205.
      4. Yang RK, Alvarez H, Lucas AS, Roy-Chowdhuri S, Rashid A, Chen H, Ballester LY, Sweeney K, Routbort MJ, Patel KP, Luthra R, Medeiros L, Toruner GA. Microsatellite instability and high tumor mutational burden detected by next generation sequencing are concordant with loss of mismatch repair proteins by immunohistochemistry. Cancer Genet 290-291:44-50, 2025. e-Pub 2025. PMID: 39700818.
      5. Sun, H, Kang, EY, Chen, H, Sweeney, K, Suchko, M, Wu, Y, Wen, J, Krishnamurthy, S, Albarracin, C, Ding, Q, Foo, WC, Sahin, AA. Immunohistochemical assessment of HER2 low breast cancer. Breast Cancer Research and Treatment 205(2):403-411, 2024. e-Pub 2024. PMID: 38441847.
      6. Zheng L, Luthra R, Alvarez HA, Lucas F, Duose DY, Wistuba II, Fuller GN, Ballester LY, Roy-Chowdhuri S, Sweeney KJ, Rashid A, Yang RK, Chen W, Liu A, Wu Y, Albarracin C, Patel KP, Routbort MJ, Sahin AA, Ding Q, Chen H. Intragenic EGFR::EGFR.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors. Cancers (Basel) 16(1):6, 2023. e-Pub 2023. PMID: 38201434.
      7. Zabrocka E, Newman B, Levey G, Sweeney K, Oentoro J, Ryu S, Stessin A. Estrogen Receptor-negative Ductal Carcinoma In Situ (DCIS) of the Breast - an Institutional Review of Outcomes. Anticancer Res 43(9):4031-4036, 2023. e-Pub 2023. PMID: 37648296.
      8. Ai, D, Sweeney, K, Li, X. Short review of malignant adenomyoepithelioma of the breast. Human Pathology Reports 27, 2022. e-Pub 2022.
      9. Sweeney KJ, Tetzlaff MT, Vega F, Gillenwater A, Zuo Z, Gross N, Nagarajan P, Wargo J, Nelson K, Prieto VG, Torres-Cabala CA, Curry JL. Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor response. J Cutan Pathol 48(5):674-679, 2021. e-Pub 2021. PMID: 33399228.
      10. Spallone A, Woroch L, Sweeney K, Seidman R, Marcos LA. The Burden of Neurocysticercosis at a Single New York Hospital. J Pathog 2020:8174240, 2020. e-Pub 2020. PMID: 32802516.
      11. Cochrane E, Menzies A, Sweeney K, Burke W. Synchronous renal and para-aortic metastasis in a uterine serous carcinoma: A case review and clinical considerations. Gynecol Oncol Rep 28:12-14, 2019. e-Pub 2019. PMID: 30740508.
      12. Farooq F, Zarrabi K, Sweeney K, Kim J, Bandovic J, Patel C, Choi M. Multiregion Comprehensive Genomic Profiling of a Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Trilineage Differentiation. J Gastric Cancer 18(2):200-207, 2018. e-Pub 2018. PMID: 29984070.
      13. Zarrabi K, Choy T, Sweeney K, Desai V, Keresztes R. Paraneoplastic edematous dermatomyositis: A rare syndrome observed in a case of small cell lung cancer. Clin Pract 7(4):982, 2017. e-Pub 2017. PMID: 29138685.
      14. Baer L, Rogers SC, Farrelly P, Tornos C, Sweeney K. The First Case of HER2+ Invasive Ductal Carcinoma Arising From a Breast Hamartoma and Literature Review. J Natl Med Assoc 109(1):55-59, 2017. e-Pub 2017. PMID: 28259217.
      15. Zarrabi K, Sweeney K, Keresztes R. Imatinib mesylate-induced kidney injury in the treatment of a gastrointestinal stromal tumor. Case Rep Intern Med 4(1):30-34, 2017. e-Pub 2017.
      16. Califano D, Sweeney KJ, Le H, VanValkenburgh J, Yager E, O'Connor W, Kennedy JS, Jones DM, Avram D. Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis. J Clin Invest 124(1):174-87, 2014. e-Pub 2014. PMID: 24316973.
      17. Sweeney KJ, Chen H, Ai D, Bassett RL, Huo L, Wu Y, Resetkova E, Yoon EC, Wang WL, Albarracin CT. ER- /PR+ Breast Cancer Cases Across Two FDA-Approved Platforms: Incidence and Clinicopathologic Correlates. USCAP 110th Annual Meeting.

      Abstracts

      1. Sweeney KJ. Recurring Genes in Fusions in Advanced Breast Carcinoma Detected by Next-Generation Sequencing: Novel BCR and TMPRSS2 Gene Fusions. USCAP 114th Annual Meeting.
      2. Sweeney KJ. Mapping the mop3 Gene Relative to the rmr6 Gene. The University of Arizona Honors College Thesis.
      3. Sweeney KJ. Expression and Development of EAE in Mice. Albany Medical College's Eighth Annual Medical Student Investigation Day.
      4. Sweeney KJ. Establishment of a Mentorship Program Connecting Health Professional Students with Refugee Families. Family Medicine Education Consortium Northeast Region Meeting.
      5. Sweeney KJ. Anaphylaxis in an Upstate New York Emergency Department: Triggers and Treatments. American Academy of Allergy Asthma and Immunology Annual Meeting.
      6. Spallone A, Sweeney KJ. Epidemiology of Neurocysticercosis at Stony Brook University Hospital, Long Island, NY. Infectious Diseases Society of America Annual IDWeek.
      7. Zarrabi K, Sweeney KJ. Paraneoplastic Dermatomyositis with Edema: A Rare Syndrome in a Case of Small Cell Lung Cancer. 12th Annual MSSNY Resident/Fellow and Medical Student Poster Symposium.
      8. Sweeney KJ. An Unexpected Diagnosis of DIPNECH. CHEST Journal 2017 Annual Meeting.
      9. Sweeney KJ, Coldren D. Minimum Lung Tumor Cell Threshold in Fine Needle Aspiration Cell Blocks Required for Therapeutic Marker Studies. ASC’s 65th Annual Scientific Meeting.
      10. Sweeney KJ, Coldren D. Next-Generation Sequencing in a Mixed Neuroendocrine-Nonneuroendocrine Neoplasm. USCAP 107th Annual Meeting.
      11. Sweeney KJ. Relationship Between Tumor Grade and Intra-Tumor Genetic Heterogeneity Using the Mutant-Allele Tumor Heterogeneity (MATH) Score with Breast Invasive Ductal Carcinoma Data from The Cancer Genome Atlas (TCGA). USCAP 108th Annual Meeting.
      12. Sweeney KJ. PTEN Alterations in Advanced ER+ Breast Cancer: Correlation with Clinicopathologic and Molecular Features. USCAP 111th Annual Meeting.
      13. Kapoor M, Sweeney KJ. More Than Just Gynecomastia: The Spectrum of Male Breast Pathologies. Society of Breast Imaging Symposium 2023.
      14. Patel M, Sweeney KJ. The Many Faces of Invasive Lobular Carcinoma. 109th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).
      15. Ye Q, Sweeney KJ. A Prospective Study of Real Time Whole Slide Imaging of Frozen Sections for Intraoperative Evaluation of Axillary Sentinel Lymph Nodes in Breast Cancer. USCAP 113th Annual Meeting.
      16. Sun H, Sweeney KJ. SMARCA4/BRG1 Deficiency in Breast Carcinoma by Immunohistochemistry Study. USCAP 113th Annual Meeting.

      Web Publications

      1. Sweeney KJ, Lategan B. Newborn with 6 cm hepatic mass, 2017.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 20, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top